N E U R O - C E L L S®
The autologous platform product Neuro-Cells® focusses on those underlying cellular processes that neurodegenerative diseases have in common.
Our technology calls on the self-healing capacity of minimally manipulated stem cells (patient’s own cellular repair toolkit), that the body itself is unable to leverage for neurodegenerative conditions due to the blood brain barrier. Neuro-Cells® includes a mixture of stem cell types that "know" how to address these processes where they fail, and in close coordination with each other, restore the balance between them.
​
​
Neuro-Cells therapy differs from others. Neuroplast developed an EU-GMP compliant autologous cell therapy product (Neuro-Cells®) manufactured from a patient’s own bone marrow which is injected directly into the cerebrospinal compartment by lumbar administration. Neuro-Cells® successfully completed a Phase I and II clinical trial for spinal cord injury. Neuro-Cells® is the only treatment that uses the naïve (“Untouched”) stem cells manufactured in an IP protected process. ​​​​​​​
​